Clinical Trial Update: Phase I Study Of PLM-102 In Patients With Relapsed And Refractory Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

This document reports a Phase I clinical trial evaluating PLM-102 in adults with relapsed or refractory acute myeloid leukemia, which is currently not yet recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• PLM-102

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: NOT_YET_RECRUITING